13 June 2024
13 June 2024
The FDA's decision was based on the randomised, double-blind, placebo-controlled T2NOW Phase III trial.
Artificial intelligence (AI) has the potential to revolutionize drug development through improved efficiency, accuracy, and speed.
NHS England chief executive Amanda Pritchard laid out a three-point plan to help support the future of the health service.
The goal of the deal is to prioritise and speed up the development of new treatments for liver conditions.
Written Medicine is a digital solution that provides bilingual dispensing labels, described in a presentation at the NHS ConfedExpo conference in Manchester.
Lord James O'Shaughnessy, the former health minister, outlines places where the UK is falling behind other countries with clinical research.
Novotech’s vice president highlighted the APAC region’s growing clinical presence, drawing attention to Australia and South Korea.
In 2023, MASLD replaced the umbrella term of nonalcoholic fatty liver disease (NAFLD) to avoid the potentially stigmatising language of the former name.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
